Fhi 360
Clinical trials sponsored by Fhi 360, explained in plain language.
-
New birth control implant enters early human testing
Disease control OngoingThis early-stage study tests a new contraceptive implant called Casea S in 20 healthy women aged 18-45. The goal is to check how the body processes the hormone, how easy it is to remove, and if it's safe. The implant aims to prevent pregnancy for at least 78 weeks.
Phase: PHASE1 • Sponsor: FHI 360 • Aim: Disease control
Last updated May 13, 2026 16:04 UTC
-
Birth control showdown: which method boosts anemia better?
Disease control OngoingThis study looks at whether a hormonal IUS or birth control pills with iron better improve anemia in women with mild to moderate anemia who want contraception. About 405 women in Kenya will be followed for 12-18 months. The main goal is to see which method raises hemoglobin level…
Phase: NA • Sponsor: FHI 360 • Aim: Disease control
Last updated May 13, 2026 16:03 UTC